Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers, today announced the launch of its latest sterile compounding technology, KIRO Fill®, as well as its next-generation software enhancements within the PharmacyKeeper IV workflow platform.
December 5, 2019
· 4 min read